SHARED: An International Collaboration to Unravel Hepatitis C Resistance.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
10 08 2021
Historique:
received: 21 07 2021
accepted: 28 07 2021
entrez: 28 8 2021
pubmed: 29 8 2021
medline: 28 1 2022
Statut: epublish

Résumé

The advent of direct-acting antivirals (DAAs) has transformed the treatment landscape of hepatitis C [...].

Identifiants

pubmed: 34452444
pii: v13081580
doi: 10.3390/v13081580
pmc: PMC8402898
pii:
doi:

Substances chimiques

Antiviral Agents 0

Types de publication

Editorial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176
pubmed: 28404132
N Engl J Med. 2015 Dec 31;373(27):2599-607
pubmed: 26571066
Open Forum Infect Dis. 2021 Jan 06;8(2):ofab006
pubmed: 33614815
J Hepatol. 2019 Dec;71(6):1070-1072
pubmed: 31648816
J Virus Erad. 2018 Jul 1;4(3):179-181
pubmed: 30050681
Gastroenterol Hepatol (N Y). 2015 Jun;11(6 Suppl 3):1-23
pubmed: 26504459
Sci Rep. 2016 Feb 04;6:20310
pubmed: 26842909
Lancet Gastroenterol Hepatol. 2019 Feb;4(2):127-134
pubmed: 30555048
N Engl J Med. 2015 Dec 31;373(27):2608-17
pubmed: 26575258
J Hepatol. 2016 Feb;64(2):486-504
pubmed: 26409317
J Hepatol. 2020 Oct;73(4):794-799
pubmed: 32470499
Lancet Infect Dis. 2017 Oct;17(10):1062-1068
pubmed: 28818546
Lancet Gastroenterol Hepatol. 2019 Feb;4(2):119-126
pubmed: 30552056
J Infect Dis. 2006 Sep 15;194 Suppl 1:S51-8
pubmed: 16921473
J Hepatol. 2021 Jun;74(6):1472-1482
pubmed: 33716089
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Clin Infect Dis. 2020 Nov 5;71(8):e215-e217
pubmed: 32055843
Hepatology. 2016 May;63(5):1430-41
pubmed: 26822022
J Hepatol. 2019 Dec;71(6):1099-1105
pubmed: 31400349

Auteurs

Anita Y M Howe (AYM)

British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada.

Francesca Ceccherini-Silberstein (F)

Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.

Julia Dietz (J)

Department of Internal Medicine 1, University Hospital, Goethe University, 65926 Frankfurt, Germany.

Stephanie Popping (S)

Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands.

Jason Grebely (J)

The Kirby Institute, UNSW Sydney, Sydney, NSW 2006, Australia.

Chaturaka Rodrigo (C)

Department of Pathology, University of New South Wales, Sydney, NSW 2006, Australia.

Johan Lennerstrand (J)

Department of Medical Sciences, Clinical Microbiology, Uppsala University, 75121 Uppsala, Sweden.

Mark W Douglas (MW)

Storr Liver Centre, The Westmead Institute for Medical Research, The University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.

Milosz Parczewsk (M)

Department of Infectious Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, 70-507 Szczecin, Poland.

P Richard Harrigan (PR)

Department of Medicine, University of British Columbia, Vancouver, BC V5Z 4R4, Canada.

Jean-Michel Pawlotsky (JM)

National Reference Center for Viral Hepatitis B, C and D, Department of Virology, Henri Mondor Hospital & INSERM U955, 94000 Créteil, France.

Federico Garcia (F)

Microbiology Department, University Hospital San Cecilio, Instituto de Investigacion Ibs.Granada, 18012 Granada, Spain.

Shared Collaborators (S)

British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH